* Access options include a subscription for Nature and 54 other journals at $32.99 for 30 days.
* An annual subscription costs $259.00 to receive 12 print issues and online access.
* Article rental or purchase prices range from $1.95 to $39.95.
* The associated DOI is 10.1038/d41591-026-00037-z.

CONSTRUCTIVE MODE: The framing positions AI as a collaborative partner in complex scientific endeavors, suggesting an extension of human research capacity. This partnership implies potential shifts in the workflow and the definition of scientific contribution, inviting questions about authorship, accountability, and the role of human intuition versus algorithmic processing in hypothesis generation. It is valuable to explore how this co-scientist dynamic changes the peer review process and knowledge dissemination mechanisms in biomedicine.
SKEPTICAL MODE: The framing leverages the prestige of Nature journals to confer immediate authority on the subject matter concerning AI in research, which carries an inherent appeal to authority. The presentation juxtaposes high-level scientific ambition with commercial access structures, creating a potential tension between open science ideals and paywalled access. The pattern observed is Authority Game due to the implicit linkage of 'Nature' branding to the utility of this new capability; the presentation relies on the perceived legitimacy of the journal ecosystem to drive engagement regarding the AI application rather than focusing solely on the empirical data generated by the co-scientist concept itself.
Root Cause: The narrative operates within a paradigm that values knowledge acceleration, which is being mediated through technological advancement. Unstated assumptions concern the potential displacement or augmentation of traditional scientific roles and the governance of AI-generated knowledge.
Implications: This framing shifts the locus of research power toward those with access to AI tools, raising questions about equitable participation in biomedical discovery and who controls the resulting intellectual property and clinical application.
Bridge Questions: How does the integration of an AI co-scientist alter established metrics for scientific rigor and novelty? What governance structures are needed to ensure transparency and accountability when AI accelerates research timelines? What are the social and ethical implications for the roles of human researchers in this new collaborative environment?